Comparative analyses of chromosome alterations in soft-tissue metastases within and across patients with castration-resistant prostate cancer. - Wikidata - wikimedia - TriplyDB

Comparative analyses of chromosome alterations in soft-tissue metastases within and across patients with castration-resistant prostate cancer.

Comparative analyses of chromosome alterations in soft-tissue metastases within and across patients with castration-resistant prostate cancer.

http://www.wikidata.org/entity/Q37408608

about

Prostate cancer progression and metastasis: potential regulatory pathways for therapeutic targeting.Using high-density DNA methylation arrays to profile copy number alterations.Identification of FBXL4 as a Metastasis Associated Gene in Prostate Cancer.Mouse models of prostate cancer: picking the best model for the question.Chromosomal aberrations in bladder cancer: fresh versus formalin fixed paraffin embedded tissue and targeted FISH versus wide microarray-based CGH analysis.Genomics screens for metastasis genes Copy number and targeted mutational analysis reveals novel somatic events in metastatic prostate tumors A three-marker FISH panel detects more genetic aberrations of AR, PTEN and TMPRSS2/ERG in castration-resistant or metastatic prostate cancers than in primary prostate tumors.Androgen receptor gene polymorphisms and alterations in prostate cancer: of humanized mice and men.Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers.Detection of somatic copy number alterations in cancer using targeted exome capture sequencing.Overexpression of IL-7 enhances cisplatin resistance in glioma Challenges in identifying candidate amplification targets in human cancers: chromosome 8q21 as a case study.Genomic and epigenomic alterations in prostate cancer.Integrative molecular profiling reveals asparagine synthetase is a target in castration-resistant prostate cancer.High-Resolution Genomic Profiling of Disseminated Tumor Cells in Prostate Cancer Novel oncogene-induced metastatic prostate cancer cell lines define human prostate cancer progression signatures.A novel four-color fluorescence in situ hybridization assay for the detection of TMPRSS2 and ERG rearrangements in prostate cancer.Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing.Genomic profiling defines subtypes of prostate cancer with the potential for therapeutic stratification Translational and clinical implications of the genetic landscape of prostate cancer.Senescent remodeling of the innate and adaptive immune system in the elderly men with prostate cancer.PPP2R2C loss promotes castration-resistance and is associated with increased prostate cancer-specific mortality.The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression.Inhibition of the PI3K/AKT/mTOR pathway activates autophagy and compensatory Ras/Raf/MEK/ERK signalling in prostate cancer The 16p13.3 (PDPK1) Genomic Gain in Prostate Cancer: A Potential Role in Disease Progression.A transgenic mouse model for early prostate metastasis to lymph nodes.The genomic landscape of prostate cancer.LuCaP Prostate Cancer Patient-Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease an--d Serve as Models for Evaluating Cancer Therapeutics.Biomarker-based targeting of the androgen-androgen receptor axis in advanced prostate cancer PTEN loss in biopsy tissue predicts poor clinical outcomes in prostate cancer.PTEN losses exhibit heterogeneity in multifocal prostatic adenocarcinoma and are associated with higher Gleason grade.Prostate Cancer Genomics: Recent Advances and the Prevailing Underrepresentation from Racial and Ethnic Minorities.Identification of frequent BRAF copy number gain and alterations of RAF genes in Chinese prostate cancer.PTEN genomic deletions that characterize aggressive prostate cancer originate close to segmental duplications

P2860

Q30409623-F57F79DC-2624-430C-B2DC-75EC9C50A1B7 Q33742976-5F6ED5AF-1EDD-41E1-BA75-98E45ABBFCFA Q33894922-503150DB-5A1A-4C16-8324-3C227376B044 Q33940867-798759E8-4847-49F8-A249-764AAAB9EDED Q34016615-6C8F5132-0413-4991-A2F0-1364804DB1DA Q34298860-6FDFB04E-C33F-48D0-89C9-2CEE363A6BD8 Q34452275-0491904B-A78E-439C-A2EA-993DED1E419E Q35009891-9A5A7DD0-9EE0-4765-A3B7-DCA0A71204E7 Q35281575-21551BBC-AE49-4680-8311-AC74DBD2B37D Q35345680-97C8B307-0756-4561-BA4A-C2108F5A0E26 Q35571880-59551265-3662-4B97-AB77-D9CB98652C88 Q36000273-1A42D2E8-39C2-4532-BD94-C4694C41CECA Q36296457-A50E4955-4C0C-4AEA-B02A-20DA494F57DC Q36374578-D6C804A0-1E86-4737-AFCE-42181831560C Q36468744-F3D82056-1919-41D8-8E24-AC8BFA707092 Q36468773-297CFA79-9EFB-4C1E-A86C-1B209FB3C312 Q36580194-6E8D7D88-A9E2-44B8-B01E-C130BB257A51 Q36784513-ED3FB1B7-1903-48D9-8EF8-579826DEDD22 Q36998629-6A30A81F-A5F8-4A4B-B096-639E56D9ED5B Q37067529-4D3E8363-ECDE-41DF-83F6-27368859C7C2 Q37270512-937C1766-CEB0-4C99-ACD0-16B8B63ADD89 Q38207592-D7EDAE00-B606-4124-89B8-577E5F14ADF7 Q39181062-835C8BE9-7DCC-44A0-B002-06CA4734C6C4 Q39628604-D5166E5B-DA2A-4EF2-921D-43FB5DD1775E Q41345175-DD576B2F-7AF5-43A5-987C-D1CAE0BA2771 Q41842962-D320506C-9B8A-4C4D-ABA3-133A42DCAE53 Q41864582-A7815853-325F-4A97-942C-9234BC3AE921 Q42174920-0738FC42-0FE7-4647-AF84-744E25B6B4C2 Q42315779-FF0F52E4-CCAA-4704-B58A-614BAC764720 Q42322498-6C4D62CB-A2EE-447E-B389-C467C868235F Q45251986-AA5DFA73-E1F2-426D-9DF5-F045F92DDB88 Q45359397-2804DA3B-6C9C-4AAE-8FF2-6E07BE71E185 Q52566012-6E363306-DDC1-4293-B4E6-2BA9F2EBA7D8 Q54494653-58634195-3424-4D96-9A8B-69A66444EB35 Q57790325-462AEDED-F57C-43B5-A843-D2CFF54248DE

P2860

Comparative analyses of chromosome alterations in soft-tissue metastases within and across patients with castration-resistant prostate cancer.

http://www.wikidata.org/entity/Q37408608

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 22 September 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Comparative analyses of chromo ...... ion-resistant prostate cancer.

@en

Comparative analyses of chromo ...... ion-resistant prostate cancer.

@nl

type

label

Comparative analyses of chromo ...... ion-resistant prostate cancer.

@en

Comparative analyses of chromo ...... ion-resistant prostate cancer.

@nl

prefLabel

Comparative analyses of chromo ...... ion-resistant prostate cancer.

@en

Comparative analyses of chromo ...... ion-resistant prostate cancer.

@nl

P1433

Q37408608-B57D3EA5-AEA4-4E82-81D0-A08D5910E32E

P1476

Q37408608-2A6F677B-F73F-41F1-98AA-981C0E498597

P2093

Q37408608-0D2EB5A1-9441-4D76-BE19-1C0A238FF525

Q37408608-12EEE6EF-AED3-4C3F-82E3-9CEC3C980754

Q37408608-25BC4EEC-AE56-4412-965D-CC9F4695E38C

Q37408608-2D36896D-554F-4568-99CD-D8DED0030852

Q37408608-4B3E716A-622A-4599-BF2F-6293D31A3554

Q37408608-565E1DC9-C55D-4614-80E1-33C4B77125FE

Q37408608-5E4D8BB0-5557-47F7-A898-EE87D692BE9A

Q37408608-7AABC5A3-BDE6-42F9-A2C9-B76BC02EFEED

Q37408608-B3B97CC8-BC46-499D-892E-136877356472

Q37408608-BD172EBB-FD35-4F05-B80F-06E26796414B

P2860

Q37408608-06D205FA-F8C2-43FB-803E-E2EAC9236B1C

Q37408608-0965E4EC-FFA2-43C9-ADC0-E992F8F933EC

Q37408608-0EEC2AE3-5438-4574-86EB-AC5F9997D435

Q37408608-12AD1CA9-68AE-4A9C-A0C1-F50D98BFAA4E

Q37408608-16BA2F42-F7E2-4169-8B6E-4951ABE3380D

Q37408608-2327EA4E-9AB4-4169-99F6-5BE9572E4122

Q37408608-2472A144-B725-4FA5-8991-5D27B138A300

Q37408608-2F532027-1E63-4199-BA79-8C6C88BEFFBD

Q37408608-31F995ED-0143-4FC7-A0E0-86B6518C60D8

Q37408608-36D65F7D-34B9-4DDD-A391-C3A9D16F447E

P304

Q37408608-614C521B-E08F-4CA6-ACEF-6C6B63840D6B

P31

Q37408608-CC84E6D7-02E9-485B-A303-F63E256CE7F6

P356

Q37408608-764BD1E2-D913-44A2-8198-5440E85E4774

P407

Q37408608-F7E72CCB-C475-49E1-9AFE-AA384E9724F3

P433

Q37408608-502EE4C6-D66E-4122-83B1-E206C99D6096

P478

Q37408608-616905F0-7D3C-4EE8-A9AB-E801B438E46E

P577

Q37408608-F9CDCF9C-4BED-40BD-B64D-0B19448C3F3F

P698

Q37408608-CABCCB01-22BF-4893-AE30-5825E031ACDE

P921

Q37408608-8B0C51E0-575A-4086-B51E-6ABB3D65FC38

P932

Q37408608-E5088D7D-C313-46D8-8DC1-D50C4C7B0D68

P356

0008-5472.CAN-08-3810

P1433

Cancer Research

P1476

Comparative analyses of chromo ...... ion-resistant prostate cancer.

@en

P2093

Barbara J Trask

http://www.w3.org/2001/XMLSchema#string

Celestia S Higano

http://www.w3.org/2001/XMLSchema#string

Colm M Morrissey

http://www.w3.org/2001/XMLSchema#string

Douglas I Grove

http://www.w3.org/2001/XMLSchema#string

Ilona N Holcomb

http://www.w3.org/2001/XMLSchema#string

Ilsa M Coleman

http://www.w3.org/2001/XMLSchema#string

Janet M Young

http://www.w3.org/2001/XMLSchema#string

Keyan Salari

http://www.w3.org/2001/XMLSchema#string

Lawrence D True

http://www.w3.org/2001/XMLSchema#string

Li Hsu

http://www.w3.org/2001/XMLSchema#string

P2860

Activation of the nuclear factor kappaB pathway by astrocyte elevated gene-1: implications for tumor progression and metastasis

Regulation of androgen receptor transcriptional activity and specificity by RNF6-induced ubiquitination

LYRIC/AEG-1 overexpression modulates BCCIPalpha protein levels in prostate tumor cells

Significance analysis of microarrays applied to the ionizing radiation response

Cluster analysis and display of genome-wide expression patterns

Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer

Three-color FISH analysis of TMPRSS2/ERG fusions in prostate cancer indicates that genomic microdeletion of chromosome 21 is associated with rearrangement

Astrocyte elevated gene-1: recent insights into a novel gene involved in tumor progression, metastasis and neurodegeneration

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation.

P304

7793-7802

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-08-3810

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P577

2009-09-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19773449

http://www.w3.org/2001/XMLSchema#string

P921

P932

2771763

http://www.w3.org/2001/XMLSchema#string